White label ELPA - ClinicalTrials.eu

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

Not yet recruiting

2 1 1
Investigated diseases:
- Asthma
+3
A study to evaluate the effect of xanomeline tartrate and trospium chloride on cognitive impairment in adults with schizophrenia.

Not yet recruiting

3 1 1
Investigated drugs:
- Trospium Chloride
- Xanomeline Tartrate
+3
A study to evaluate the use of botulinum toxin type A – haemagglutinin complex to help close the abdomen in patients with an open abdomen.

Not yet recruiting

3 1 1 1
Investigated drugs:
- Botulinum Toxin Type A – Haemagglutinin Complex
A study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction

Not yet recruiting

2 1 1 1
Investigated drugs:
- Adenosine
A study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer

Not yet recruiting

2 1 1
Investigated diseases:
- Hepatocellular carcinoma
A study of ficerafusp alfa and nivolumab in patients with head and neck cancer who did not respond to platinum-based chemotherapy.

Not yet recruiting

2 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Nivolumab
A study to evaluate the safety and effectiveness of VTX2735 sodium in patients with recurrent pericarditis

Not yet recruiting

2 1 1
Investigated drugs:
- VTX2735 SODIUM
Comparison of amoxicillin, amoxicillin-clavulanate, and placebo for the treatment of middle ear infection in children

Not yet recruiting

3 1 1
Investigated diseases:
- Otitis media
Investigated drugs:
- Amoxicillin
- Clavulanic Acid
Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

Not yet recruiting

3 1
Investigated drugs:
- Ibutamoren Mesilate
Standardization of Olea europaea pollen extract for patients with olive pollen allergies

Not yet recruiting

2 1 1
Investigated diseases:
- Hypersensitivity
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies